Human medicinal products | | SPC PL | | Veterinary medicinal
products | SPC PL | | Herbal medicinal products | | SPC PL | | Name of the medicinal
product |
| |
|
|
Package Leaflets (PL) for Human medicinal products
The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.
The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.
The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA.
Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website.
Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Product Information Leaflets 91 - 120 of 233 |
|
|
SPC | Status for supply | Name of the medicinal product |
SPC
|
Resepti
|
Firekol 500 mikrog tabletti, kalvopäällysteinen PL 2024-02-01
|
|
|
European Medicines Agency's website: Firmagon - EMA: EPAR PI
Finnish Swedish
|
SPC
|
Resepti
|
Fixopost 50 mikrog-ml + 5 mg-ml silmätipat, liuos, kerta-annospakkaus PL 2022-03-09
|
SPC
|
Resepti
|
Flagyl 400 mg tabletti, kalvopäällysteinen PL 2022-12-02
|
SPC
|
Resepti
|
Flagyl 500mg emätinpuikko PL 2022-12-02
|
SPC
|
Resepti
|
Flagyl comp Emätinpuiko PL 2022-12-02
|
SPC
|
Itsehoito
|
Flavamed 30 mg tabletti PL (OTC) 2023-06-14
|
SPC
|
Resepti
|
Flavamed 30 mg tabletti PL (Rx) 2023-06-14
|
SPC
|
Itsehoito
|
Flavamed 6 mg-ml oraaliliuos OTC PL 2024-05-23.docx
|
SPC
|
Resepti
|
Flavamed 6 mg-ml oraaliliuos PL 2020-07-09
|
SPC
|
Resepti/itsehoito
|
Flavamed 60 mg poretabletti OTC PL 2023-12-15
|
SPC
|
Resepti
|
Flavamed 60 mg poretabletti PL 2021-01-29
|
|
|
European Medicines Agency's website: Flebogamma DIF (ent. Flebogammadif) - EMA: EPAR PI
Finnish Swedish
|
SPC
|
Resepti
|
Flecainide Orion 100 mg, 200 mg depotkapseli, kova PL 2018-11-12
|
SPC
|
Resepti
|
Flexilev 5 mg-1.25 mg dispergoituva tabletti annostelulaitteeseen PL 2024-05-30
|
SPC
|
Resepti
|
Flexiloges tabletti kalvopäällysteinen pakkausseloste 2022-01-28.docx
|
|
|
European Medicines Agency's website: Flixabi - EMA: EPAR PI
Finnish Swedish
|
SPC
|
Resepti
|
Flixonase 50 mikrog- annos nenäsumute PL 2023-04-14.doc
|
SPC
|
Itsehoito
|
Flixonase 50 mikrog-annos nenäsumute OTC PL 2023-04-14.doc
|
SPC
|
Resepti
|
Flixotide Diskus 100, 250, 500 mikrog-annos inhalaatiojauhe, annosteltu PL 2023-05-01
|
SPC
|
Resepti
|
Flixotide Evohaler 50, 125 ja 250 mikrog-annos inhalaatiosumute, suspensio PL 2023-05-01
|
SPC
|
Resepti
|
Flixotide Evohaler 50, 125 ja 250 mikrog-annos inhalaatiosumute, suspensio PL 2023-05-01
|
SPC
|
Resepti
|
Florinef 0.1 mg tabletti PL 2020-09-22
|
|
|
European Medicines Agency's website: Fluad Tetra - EMA: EPAR PI
Finnish Swedish
|
SPC
|
Resepti
|
Fluanxol 0.5 mg, 1 mg tabletti, kalvopäällysteinen PL 2020-10-13
|
SPC
|
Resepti
|
Fluanxol 5 mg tabletti, kalvopäällysteinen PL 2020-10-13
|
SPC
|
Resepti
|
Fluarix Tetra injektioneste, suspensio, esitäytetty ruisku PL 2024-04-09
|
|
|
European Medicines Agency's website: Flucelvax Tetra - EMA: EPAR PI
Finnish Swedish
|
SPC
|
Resepti
|
Flucloxacillin Orion 500 mg, 750 mg, 1 g tabletti, kalvopäällysteinen PL 2024-02-22
|
SPC
|
Resepti
|
Flucloxacillin Orion 500 mg, 750 mg, 1 g tabletti, kalvopäällysteinen PL 2024-02-22
|
|
| |